Literature DB >> 27695624

Citalopram and escitalopram: adverse cardiac outcomes in medically ill inpatients.

Dominique Elie1, Saeid Noohi2, André Do2, Artin Mahdanian2, Ching Yu2, Marilyn Segal2, Karl J Looper2, Soham Rej3.   

Abstract

Entities:  

Year:  2016        PMID： 27695624      PMCID： PMC5014051          DOI： 10.1177/2042098616660947

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  5 in total

1.  Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents.

Authors:  Harry J Witchel; Vijay K Pabbathi; Giovanna Hofmann; Ashok A Paul; Jules C Hancox
Journal:  FEBS Lett       Date:  2002-02-13       Impact factor: 4.124

2.  Evaluation of a QT nomogram for risk assessment after antidepressant overdose.

Authors:  W Stephen Waring; Ann Graham; Julie Gray; Allen D Wilson; Catherine Howell; D Nicholas Bateman
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

Review 3.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 4.  Cardiovascular effects of antidepressant drugs: updated.

Authors:  A H Glassman
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

5.  QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.

Authors:  Ingrid M M van Haelst; Wilton A van Klei; Hieronymus J Doodeman; Miriam J Warnier; Marie L De Bruin; Cor J Kalkman; Toine C G Egberts
Journal:  J Clin Psychiatry       Date:  2014-01       Impact factor: 4.384
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.